Wang Ting, Tao Wei, Zhang Lei, Li Shengli
Department of Hematology.
Department of Neurology.
Onco Targets Ther. 2017 Sep 11;10:4465-4474. doi: 10.2147/OTT.S143612. eCollection 2017.
microRNAs are important in cancer biogenesis and development. However, their underlying mechanisms in multiple myeloma (MM) are barely characterized. microRNA-20a (miR-20a) is a member of the microRNA-17-92 cluster. It has been implicated in various cancers, regulating the proliferation and invasion of cancer cells in vitro. Compared with healthy donors, it also has been reported to be elevated in plasma of MM patients. Here, we investigated the function of miR-20a. Our results showed that it promotes proliferation and inhibits apoptosis of MM cells in vitro by inhibiting early growth response protein 2. The effects of miR-20a were also evaluated in MM xenograft models of SCID/NOD mice. Apparent antitumor activity was achieved in xenograft mice injected with miR-20a inhibitor, while mimics of miR-20a significantly promoted tumor growth. These data indicate that miR-20a plays a crucial role in the biology of MM and represents a potential target for novel therapies for MM patients.
微小RNA在癌症的发生和发展中起着重要作用。然而,它们在多发性骨髓瘤(MM)中的潜在机制却鲜有研究。微小RNA-20a(miR-20a)是微小RNA-17-92簇的成员之一。它与多种癌症相关,在体外可调节癌细胞的增殖和侵袭。与健康供体相比,据报道MM患者血浆中的miR-20a水平也有所升高。在此,我们研究了miR-20a的功能。我们的结果表明,它通过抑制早期生长反应蛋白2在体外促进MM细胞的增殖并抑制其凋亡。我们还在SCID/NOD小鼠的MM异种移植模型中评估了miR-20a的作用。注射miR-20a抑制剂的异种移植小鼠表现出明显的抗肿瘤活性,而miR-20a模拟物则显著促进肿瘤生长。这些数据表明,miR-20a在MM生物学中起着关键作用,是MM患者新型治疗的潜在靶点。